ATI LPN · ATI LPN Capstone · PN ATI Capstone Proctored Comprehensive Assessment 2020 A with NGN

Option B: Renal function should be monitored in clients prescribed gabapentin due to the drug's primary excretion via the kidneys. Impaired renal function can lead to increased drug levels and a higher risk of adverse effects, necessitating dosage adjustments based on renal clearance.

Option A: Liver function tests are not routinely required for gabapentin monitoring, as the drug is not significantly metabolized by the liver. Thus, liver function does not impact gabapentin therapy.

Option C: Blood glucose levels are not specifically monitored for patients on gabapentin unless there is a concurrent condition requiring such monitoring. Gabapentin does not directly affect glucose metabolism.

Option D: Cardiac rhythm monitoring is not necessary for gabapentin administration, as the medication does not have significant cardiovascular effects that would warrant such observation.

Takeaways: Monitoring renal function is essential for clients on gabapentin due to its renal excretion and potential for toxicity in cases of impaired kidney function, which requires appropriate dosage adjustments to ensure safety and efficacy.

Option C: Bradykinesia is a hallmark manifestation of Parkinson's disease, characterized by a gradual reduction in the speed and amplitude of movements. This symptom significantly impacts daily activities and is a key indicator of the disease's progression.

Option A: Pruritus is not a typical manifestation of Parkinson's disease and is more commonly associated with dermatological conditions or systemic diseases.

Option B: Hypertension is not a primary feature of Parkinson's disease; rather, patients may experience orthostatic hypotension due to autonomic dysfunction associated with the condition.

Option D: Xerostomia, or dry mouth, can occur in various conditions but is not a defining symptom of Parkinson's disease, which primarily involves motor and non-motor symptoms related to movement control.

Takeaways: Bradykinesia is a key symptom of Parkinson's disease, reflecting the motor control deficits characteristic of the condition, and requires patient education on managing symptoms to enhance quality of life.

Option B: Verify the blood type and crossmatch is the first action the nurse should take before administering a blood transfusion. This step ensures compatibility between the donor blood and the recipient, significantly reducing the risk of transfusion reactions and enhancing patient safety.

Option A: Obtain the client's consent should follow the verification of blood type and crossmatch. Consent is important, but it must occur after confirming the correct blood product is available for transfusion.

Option C: Take baseline vital signs is essential for monitoring the patient during the transfusion, but it should be done after verifying blood type and crossmatch to ensure the correct blood is administered.

Option D: Prime the IV with normal saline is necessary for preparing the IV line, but this action should occur after confirming the blood type and crossmatch to avoid any risk of administering incompatible blood.

Takeaways: Ensuring blood type and crossmatch verification is critical to patient safety during blood transfusions, as it prevents potential transfusion reactions and requires proper protocols for blood transfusion administration to be followed meticulously.

Option B: Dizziness is a significant adverse effect of amlodipine that may indicate hypotension or other cardiovascular issues. Clients should be instructed to report dizziness to ensure timely assessment and management of potential complications.

Option A: Dry cough is typically associated with ACE inhibitors, not calcium channel blockers like amlodipine. Therefore, it is not a relevant adverse effect to monitor in this context.

Option C: Rash can occur with various medications, but it is not a common or significant adverse effect of amlodipine. Clients should monitor for other more critical symptoms.

Option D: Headache may occur with amlodipine use but is generally not a serious adverse effect that requires immediate reporting unless it is severe or persistent.

Takeaways: Monitoring for dizziness is crucial when administering amlodipine, as it may indicate hypotension or other serious issues; clients should be educated on the importance of reporting such symptoms to ensure safety and effective management of hypertension. For more information on managing hypertension, refer to CDC guidelines on hypertension.

Option A: It can cause sedation. Gabapentin is known to have sedative effects, which can impact a patient's ability to perform tasks that require alertness, such as driving. Educating patients about this potential side effect is crucial for their safety and awareness of how the medication may affect them.

Option B: It can be taken with alcohol. Combining gabapentin with alcohol can enhance sedative effects, increasing the risk of respiratory depression and other adverse effects. Patients should be advised to avoid alcohol while taking this medication.

Option C: It is a pain reliever. Gabapentin is primarily used for neuropathic pain and seizures, but it is not classified as a traditional pain reliever like NSAIDs or opioids. This distinction is important for patient understanding of its use.

Option D: It has no side effects. Gabapentin does have side effects, including dizziness, fatigue, and sedation. Providing accurate information about potential side effects is essential for informed patient consent and safety.

Takeaways: Educating patients about gabapentin includes discussing its potential to cause sedation and the importance of avoiding alcohol, as well as clarifying its role in managing neuropathic pain rather than being a conventional pain reliever. For more detailed information, refer to gabapentin patient education resources.